A Pilot Study to Assess the Performance of Phase-Sensitive Breast Tomosynthesis

Laurie L Fajardo1, Stephen L Hillis1, Bin Zheng1

  • 1From the Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah (L.L.F., P.J., M.E.P.); Departments of Radiology and Biostatistics, University of Iowa, Iowa City, Iowa (S.L.H.); Advanced Medical Imaging Center and School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK 73019 (B.Z., M.D.W., M.U.G., F.H.O., Y.L., H.L.); and Department of Radiology, University of Alabama at Birmingham, Birmingham, Ala (X.W.).

Radiology
|September 27, 2022
PubMed
Summary

Phase-sensitive breast tomosynthesis (PBT) offers a 24% radiation dose reduction compared to digital breast tomosynthesis (DBT). While image quality was lower, diagnostic performance was similar in this pilot study.